Latest Cytori Stories

2012-03-19 19:16:39

Cytori Therapeutics (NASDAQ: CYTX) announced today the publication of RESTORE-2 trial results in the peer-reviewed European Journal of Surgical Oncology. RESTORE-2 is a 71 patient multi-center, prospective clinical trial using autologous adipose-derived regenerative cell (ADRC)-enriched fat grafting for reconstruction of the breast after cancer surgery. The majority of patients underwent radiation prior to the procedure, creating an unfavorable ischemic environment for which breast...

2008-11-13 09:00:37

Cytori (NASDAQ: CYTX) received its first order from Green Hospital Supply for a StemSource(R) Cell Bank, which will be installed in one of the leading public universities in Japan. This is an important development for Cytori, as the cell bank will be installed at a prestigious academic hospital and will have significant visibility in the Japanese market. The size and geographic reach of the hospital will benefit a large population of patients. In addition, the hospital's well known...

2008-09-24 09:00:49

Two surgeons today reported their experience in performing cell-enhanced reconstruction on 52 patients from Europe and Israel. The procedures included breast reconstruction post-partial mastectomy, breast implant salvage, as well as facial and other cosmetic applications, demonstrating the increased clinical utility for cell-enhanced reconstruction. The results are consistent with previously reported outcomes of cell-enhanced reconstruction. This is a procedure whereby an autologous fat...

2008-08-08 12:00:45

Cytori (NASDAQ: CYTX) will host its second quarter results conference call at 10:30 am Eastern Daylight Time, not 10:00 am. About Cytori Cytori's (NASDAQ: CYTX) goal is to be the global leader in regenerative medicine. The company is dedicated to providing patients with new options for reconstructive surgery, developing treatments for cardiovascular disease, and banking patients' adult stem and regenerative cells. The Celution(R) 800 System is being introduced in Europe into the...

2008-07-14 12:00:00

Cytori (NASDAQ:CYTX) sold its first European Union StemSource(R) Cell Bank as part of an agreement with Biohellenika (www.biohellenika.gr). Biohellenika, the leading provider of cord blood stem cell banking services in Greece, will be the exclusive provider of the StemSource Cell Bank cryopreservation services in Greece, which is one of the largest markets for cell banking in Europe. The StemSource Cell Bank is a comprehensive product offering, which allows companies or hospitals to...

Word of the Day
  • A 'bachelor seal'; a young male seal which is prevented from mating by its herd's older males (mated bulls defending their territory).
This comes from the Russian word for 'bachelors.'